Dengue fever is a common tropical infection. This acute febrile illness can be a deadly infection in cases of severe manifestation, causing dengue hemorrhagic shock. In this brief article ...
The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.
The Quezon City government declared a dengue outbreak on Saturday amid the steep rise in the number of residents contracting ...
The unusual strategy adopted by the Addition Hills village in Mandaluyong city in metropolitan Manila reflects growing ...
Island noted that high-level results from the phase 2b studies were anticipated in the next six to eight weeks. Dengue fever ...
All subjects enrolled in Island Pharmaceutical’s phase 2b arm of phase 2a/b PROTECT trial of ISLA-101 in dengue fever Phase 2b study will explore ability of ISLA-101 to reduce symptoms of a ...
All subjects have now been enrolled in Island Pharmaceutical’s phase 2b arm of its ISLA-101 trial in dengue fever. Don't miss out on the headlines from Stockhead. Followed categories will be ...
Island Pharmaceuticals has completed subject dosing for the phase 2b therapeutic arm of its phase 2a/b PROTECT clinical trial of ISLA-101 in dengue fever. Island Pharmaceuticals Ltd (ASX:ILA)said ...